Buspirone Hydrochloride Tablet
FDA Label NDC 24689-933

14 label sections · Submitted to the FDA by Apnar Pharma Lp · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Apnar Pharma Lp for the product Buspirone Hydrochloride (NDC 24689-933). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, warnings, precautions, adverse reaction (see also precautions), drug abuse and dependence, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.